
Company Information
Ask for more detail from the seller
Contact SupplierTafinlar is a cancer medicine used to treat adults whose cancer cells have a specific genetic mutation (change) called ‘BRAF V600’. It is used for the treatment of:
melanoma (a skin cancer) that has spread or cannot be removed surgically. Tafinlar is used on its own or in combination with another cancer medicine, trametinib;
advanced (stage III) melanoma after surgery for it. Tafinlar is used in combination with trametinib;
advanced non-small cell lung cancer. It is used in combination with trametinib.
Tafinlar contains the active substance dabrafenib.Tafinlar is a cancer medicine used to treat adults whose cancer cells have a specific genetic mutation (change) called ‘BRAF V600’. It is used for the treatment of:
melanoma (a skin cancer) that has spread or cannot be removed surgically. Tafinlar is used on its own or in combination with another cancer medicine, trametinib;
advanced (stage III) melanoma after surgery for it. Tafinlar is used in combination with trametinib;
advanced non-small cell lung cancer. It is used in combination with trametinib.
Tafinlar contains the active substance dabrafenib.Tafinlar is a cancer medicine used to treat adults whose cancer cells have a specific genetic mutation (change) called ‘BRAF V600’. It is used for the treatment of:
melanoma (a skin cancer) that has spread or cannot be removed surgically. Tafinlar is used on its own or in combination with another cancer medicine, trametinib;
advanced (stage III) melanoma after surgery for it. Tafinlar is used in combination with trametinib;
advanced non-small cell lung cancer. It is used in combination with trametinib.
Tafinlar contains the active substance dabrafenib.